Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 8/20 | 0.44 |
| ▸ | AHR | P35869 | 2/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19058194 | 0.94 | PDK2 (0.45) | PDK2AHRKDM4EKMT2AMAPK1 | |
| SCHEMBL19152841 | 0.87 | PDK2 (0.55) | PDK2AKR1A1AKR1B1THRBTDP1 | |
| SCHEMBL22891352 | 0.84 | PDK2 (0.41) | PDK2AHRKDM4EKMT2AMAPK1 | |
| SCHEMBL22933916 | 0.82 | PDK2 (0.41) | PDK2AHRKDM4EKMT2AMAPK1 | |
| SCHEMBL19797279 | 0.82 | PDK2 (0.51) | PDK2AKR1A1AKR1B1KDM4EKMT2A | |
| SCHEMBL19058235 | 0.80 | PDK2 (0.44) | PDK2AHRAKR1A1AKR1B1KDM4E | |
| SCHEMBL824181 | 0.78 | PDK2 (0.47) | PDK2AKR1A1AKR1B1THRBTDP1 | |
| SCHEMBL31497073 | 0.78 | PDK2 (0.46) | PDK2AKR1A1AKR1B1 | |
| SCHEMBL22113308 | 0.77 | PDK2 (0.41) | PDK2AKR1A1AKR1B1MAPK1 | |
| SCHEMBL19357064 | 0.77 | PDK2 (0.61) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11066382-B2 | Organic compound and organic electroluminescent device comprising same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2021-07-20 | — | — | US | disclosed |
| US-11066382-B2 | Organic compound and organic electroluminescent device comprising same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2021-07-20 | — | — | US | disclosed |
| US-20180346439-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | DOOSAN CORPORATION (KR) | 2018-12-06 | — | — | US | disclosed |
| WO-2017111544-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 두산 | 2017-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180346439-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | OR10J3, L1CAM, ORC3 | PDK2 1221/4885AHR 3282/4885AKR1A1 4237/4885 |
| US-11066382-B2 | Organic compound and organic electroluminescent device comprising same | OR10J3, L1CAM, ORC3 | PDK2 1221/4885AHR 3282/4885AKR1A1 4237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.